Phase I Trial of CCL21 Gene Modified Dendritic Cells in Lung Cancer Elicits Immune Responses
2017 ◽
Vol 12
(8)
◽
pp. S1537
J.M. Lee
◽
E.B. Garon
◽
J.W. Goldman
◽
F. Abtin
◽
R. Suh
◽
...
2017 ◽
Vol 23
(16)
◽
pp. 4556-4568
◽
Jay M. Lee
◽
Mi-Heon Lee
◽
Edward Garon
◽
Jonathan W. Goldman
◽
Ramin Salehi-Rad
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS157-TPS157
◽
J. M. Lee
◽
E. B. Garon
◽
F. Baratelli
◽
D. Schaue
◽
P. S. Pak
◽
...
2008 ◽
Vol 6
(1)
◽
pp. 38
◽
Felicita Baratelli
◽
Hiroko Takedatsu
◽
Saswati Hazra
◽
Katherine Peebles
◽
Jie Luo
◽
...
1997 ◽
Vol 100
(9)
◽
pp. 2218-2226
◽
H Gahéry-Ségard
◽
V Molinier-Frenkel
◽
C Le Boulaire
◽
P Saulnier
◽
P Opolon
◽
...
2009 ◽
Vol 75
(3)
◽
pp. S110
◽
J.H. Heinzerling
◽
R.S. Hughes
◽
R. Govindan
◽
J.D. Bradley
◽
J.D. Schiller
◽
...
2011 ◽
Vol 69
(2)
◽
pp. 563-571
◽
Heather A. Wakelee
◽
Chris H. Takimoto
◽
Arturo Lopez-Anaya
◽
Quincy Chu
◽
Gary Middleton
◽
...
Toshivoshi Fujiwara
◽
Masafumi Kataoka
◽
Atsushi Nakamura
◽
Noriaki Tanaka
2005 ◽
Vol 49
◽
pp. S269-S270
D. Stewart
◽
Y. Oh
◽
R. Schaerer
◽
L. Naumobski
◽
S. Phan
S. Swann
◽
H. Choy
◽
C. Walter
◽
G. Whipple
◽
W. Demas
◽
...